Search For "non small cell lung cancer"
Anatomic lung resection linked to improved survival for early-stage lung c
Updated : 8 months ago IST
New research presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting reveals that anatomic lung resections, such as lobectomy and segmentectomy, are associated with better long-term survival than wedge resection for patients with early-stage non-small cell lung cancer (NSCLC)
Read More
Researchers find how precision radiation treatment supports in lung cancer
Updated : 8 months ago IST
For patients with locally advanced, unresectable non-small cell lung cancer (NSCLC), standard use of the more accurate intensity-modulated radiation therapy (IMRT) is recommended over the alternative 3D-conformal radiation therapy (3D-CRT).
Read More
Study finds how type of allergy remedy help treat lung cancer
Updated : 8 months ago IST
Researchers at Mount Sinai's Icahn School of Medicine have discovered an allergy route that, when inhibited, activates antitumor immunity in animal models of non-small cell lung cancer (NSCLC).
Read More
Immunotherapy for lung cancer patients improves long-term survival: Study
Updated : 2 years, 11 months ago IST
The cancer immunotherapy atezolizumab1 significantly increased the overall survival of patients with advanced stage non-small cell lung cancer who were unable to receive platinum-containing chemotherapy when compared to single-agent chemotherapy, according to a global study conducted by UCL
Read More
Study reveals new way to preserve lung tissue in cancer patients
Updated : 3 years, 2 months ago IST
A lobectomy, in which the entire lung lobe is removed, is the standard medical procedure for treating early-stage non-small cell lung cancer
Read More
Simultaneous radiation, immunotherapy beneficial for subset of lung cancer
Updated : 3 years, 6 months ago IST
In many cancer types, cancer cells try to survive by escaping attack from the immune system. These cancer cells hijack mechanisms called immune checkpoints to trick the immune system into thinking they are healthy cells. Recent advances in cancer treatment have focused on developing immune c
Read More
Early clinical trial of targeted lung cancer drug suggests it can be helpf
Updated : 3 years, 7 months ago IST
Certain type of non-small cell lung cancer (NSCLC) patients can be helped by repotrectinib usage, suggests early trials of the targeted drug.
Read More
Researchers working on reducing lung cancer medication resistance
Updated : 3 years, 7 months ago IST
Missouri [US], October 20 (ANI): After 14 months, there is a 70-80 per cent risk that non-small cell lung cancer, one of the two primary types of lung cancer, would become resistant to the pharmacological therapy that was initially used to treat it. There aren't many existing therapy alterna
Read More
Study finds drug resistance to fight lung cancer
Updated : 3 years, 7 months ago IST
Columbia [US], October 20 (ANI): When a person is diagnosed with non-small cell lung cancer, one of the two primary types of lung cancer, there is a 70-80 per cent risk that cancer will acquire resistance to the initial medication therapy used to treat it after 14 months. If this occurs, the
Read More
Researchers discover new cancer treatments in 'dark matter' of human genom
Updated : 3 years, 7 months ago IST
Washington [US], October 7 (ANI): Researchers have developed a screening method to discover new drug targets for cancer treatment in the so-called 'Dark Matter' of the genome. They applied their method to non-small cell lung cancer (NSCLC), the greatest cancer killer for which effective ther
Read More
Radiation elevates cardiac risk in lung cancer patients: Study
Updated : 6 years, 11 months ago IST
Washington D.C. [USA], June 11 (ANI): Patients getting treated for locally advanced non-small cell lung cancer (NSCLC) are at a risk of heart attack and heart failure, a recent study has observed.
Read More
Genetic mutations may drive tumor formation
Updated : 7 years, 9 months ago IST
Washington D.C [USA], Sep 01 (ANI): A new study has found that genetic mutations in the form of non-small cell lung cancer (NSCLC) may drive tumor formation by blurring cells' perception of key growth signals.
Read More